1. Xiang, Junyu, Zhang, Ni, Sun, Hui, Liu, Chungang, Qian, Cheng. 2019. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells. In Gastroenterology, 158, 664-678.e24. doi:10.1053/j.gastro.2019.10.025. https://pubmed.ncbi.nlm.nih.gov/31678303/
2. Wang, Lingyan, Liu, Jin, Wang, Zhuoran, Yang, Yuqiao, Qian, Jinqiao. 2023. Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 165, 115255. doi:10.1016/j.biopha.2023.115255. https://pubmed.ncbi.nlm.nih.gov/37549462/
3. Kim, Ye-Ji, Oh, Jeein, Jung, Soohan, Crotty, Shane, Choi, Youn Soo. 2023. The transcription factor Mef2d regulates B:T synapse-dependent GC-TFH differentiation and IL-21-mediated humoral immunity. In Science immunology, 8, eadf2248. doi:10.1126/sciimmunol.adf2248. https://pubmed.ncbi.nlm.nih.gov/36961907/
4. Zhang, Pengcheng, Lu, Rui. . The Molecular and Biological Function of MEF2D in Leukemia. In Advances in experimental medicine and biology, 1459, 379-403. doi:10.1007/978-3-031-62731-6_17. https://pubmed.ncbi.nlm.nih.gov/39017853/